Literature DB >> 33398368

circFOXO3 protects cardiomyocytes against radiation‑induced cardiotoxicity.

Yiming Qiu1, Xianping Xie1, Luhua Lin1.   

Abstract

Radiation therapy, one of the major treatment options for cancer, can cause delayed heart damage. The circular RNA (circRNA) circFOXO3 (hsa_circ_0006404) is associated with cancer progression. However, the functions of circFOXO3 in radiation‑induced cardiotoxicity remains unknown. The present study aimed to identify the functions of cirFOXO3 in radiation‑induced cardiotoxicity. The present study established circFOXO3‑knockdown (KD) or ‑overexpressing (OE) cardiomyocytes. Functional assay results showed that KD of circFOXO3 in cardiomyocytes significantly increased DNA damage and apoptosis after radiation. By contrast, OE of circFOXO3 reduced DNA damage and apoptosis rates in response to radiation. Mechanistically, KD of circFOXO3 elevated the levels of Bax, caspase 3 and caspase 7, and decreased Bcl‑2 expression, whereas OE of circFOXO3 decreased Bax, caspase 3 and caspase 7 expression, and increased Bcl‑2 expression. Thus, the present study indicated that circFOXO3 protected cardiomyocytes from radiation‑induced cardiotoxicity by reducing DNA damage and apoptosis. circFOXO3 may be a potential therapeutic target against radiation‑induced cardiotoxicity.

Entities:  

Year:  2021        PMID: 33398368     DOI: 10.3892/mmr.2020.11816

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  2 in total

1.  Circular RNA Foxo3 Relieves Myocardial Ischemia/Reperfusion Injury by Suppressing Autophagy via Inhibiting HMGB1 by Repressing KAT7 in Myocardial Infarction.

Authors:  Guang Sun; Jian-Fen Shen; Xiu-Fang Wei; Guo-Xian Qi
Journal:  J Inflamm Res       Date:  2021-12-01

Review 2.  Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments.

Authors:  Wanli Sun; Juping Xu; Li Wang; Yuchen Jiang; Jingrun Cui; Xin Su; Fan Yang; Li Tian; Zeyu Si; Yanwei Xing
Journal:  Front Cardiovasc Med       Date:  2022-08-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.